The emerging landscape of cancer care points towards a radically personalized approach. Departing from the “one-size-fits-all” model, the future of authentic cancer treatment copyrights on combining multi-omics data – including genomics, proteomics, and metabolomics – to precisely profile individual patients . It are poised to allow for the